Gender | Clinical form | ECG | Cardiac manifestations | Risk class | Therapy | Age at diagnosis |
---|---|---|---|---|---|---|
M:18 (69.2%) | T: 14 (53.8%) | N: 12 (46.2%) | NCI: 14 (54%) | I: 20 (76.9%) | ASA + IVIG 20 (76.9%) | < 6 ms: 2 (7.7%) |
F:8 (30.8%) | I: 9 (34.6%) | SST: 9 (34.6%) | TAC: 3 (11.5%) | II: 3 (11.5%) | ASA 3 (11.5%) | 6 ms- 5 ys: 21 (80.8%) |
A: 3 (11.5%) | PRBBB: 3 (11.5%) | PAC: 3 (11.5%) | III: 2 (7.7%) | IVIG 2 (7.7%) | > 5 ys:3 (11.5%) | |
NSDVR: 2 (7.7%) | PE: 3 (11.5%) | IV: 1 (3.9%) | No therapy 1 (3.9%) | |||
MR: 3 (11.5%) |